Overarching policy for delivering medication assisted treatment for opioid dependence in Victoria.
Medical practitioners may now prescribe buprenorphine/naloxone (Suboxone®) for up to five patients without the need to attend the one-day Pharmacotherapy GP Training Program. Medical practitioners may refer to the following guide for advice on the key regulatory and policy requirements for prescribing buprenorphine/naloxone. An online video, produced by Networking Health Victoria, is also available.A brief guide to prescribing buprenorphine/naloxone
(pdf) A guide for medical practitioners prescribing buprenorphine/naloxone under the five-patient-limit rules.
(RACGP video - approx. 15 mins)
Commonwealth Department of Health, April 2014
The Royal Australian College of General Practitioners provides online and face-to-face pharmacotherapy training for General Practitioners in two parts: Module 1 and Module 2. The online learning module, Safer Opioid Prescribing, is a pre-requisite for attending the one-day Pharmacotherapy GP Training Program, Module 2.
This training is supported via the hapn network through promotion, on-the-day attendance and a follow-up program, including by linking delegates with experienced prescribers for advice and mentoring, when required.
All links provided are direct links to the Victorian Department of Health original documents unless specified. A list of all Department pharmacotherapy forms can be found here. health.vic.gov.au/dpcs/pharm.htm